Journal Article Summary
The article investigates the safety of hormonal contraceptives, particularly combined oral contraceptives (COCs), in women who experience migraines. This topic is significant because both migraines and the use of COCs have been linked to an increased risk of ischemic stroke, a serious medical condition. Understanding the relationship between these factors is crucial for women of reproductive age who may be considering hormonal contraception, especially those with a history of migraines.
The researchers conducted a systematic review of existing studies, focusing on women with migraines and their use of hormonal contraceptives. They identified seven relevant studies, all of which were case-control studies examining the risk of stroke associated with COC use among women with migraines. The findings suggest that women with migraines who use COCs may face a two- to fourfold increased risk of stroke compared to those who do not use hormonal contraceptives. However, the evidence was limited and varied in quality, with only one study specifically analyzing migraine subtypes.
Despite the findings, the review highlights several limitations, including the overall poor quality of the studies and the lack of differentiation between migraine types. This means that the results should be interpreted cautiously. Patients are encouraged to discuss their individual risk factors, including migraine history and the use of hormonal contraceptives, with their healthcare providers. This conversation is essential to make informed decisions about contraceptive options and to understand the potential risks involved.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Tepper Naomi K., Whiteman Maura K., Zapata Lauren B., Marchbanks Polly A., Curtis Kathryn M.. Safety of hormonal contraceptives among women with migraine: A systematic review☆. Contraception 2016. DOI: 10.1016/j.contraception.2016.04.016. PMID: 27153744. PMCID: PMC11022834.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
